Closing Market Summary: Stocks Climb Amid Rebound in FinancialsThe stock market ended a bumpy week on a higher note with all three major averages climbing near 0.8%. The S&P 500 (+0.8%) rallied into the late afternoon, but selling during the final minutes of the session drove the index just below its 50-day moving average (2168.4), which acted as resistance throughout the month. The S&P 500 gained 0.2% for the week, but shed 0.1% for the month. The benchmark index advanced 3.3% during the third quarter, underperforming the Nasdaq (+0.8%), which climbed 9.7% in Q3 and gained 1.9% in September.
Deutsche Bank (DB 13.09, +1.61) dominated headlines for the second day in a row, but today's focus was on a rebound in the stock amid reassurances from the bank's Chief Executive Officer John Cryan. Mr. Cryan sent a letter to employees, in which he described the bank's capital position as solid, noting that liquid reserves are well above pre-crisis levels from 2007. The stock doubled its late-morning gain, ending higher by 14.0%, after AFP reported the bank's MBS settlement with the Department of Justice will be reduced to $5.4 billion from $14.0 billion. The report was not confirmed by Deutsche Bank and it is worth noting that markets in Germany will be closed on Monday in observance of Unification Day.
The rebound in Deutsche Bank boosted sentiment in the financial sector (+1.4%), which narrowed its September loss to 2.9%, but still ended the month well behind the other ten sectors. Friday's sector-wide rally did not stop Wells Fargo (WFC 44.55, +0.18) from ending in the red as the stock set a fresh low for the year (44.10). The stock spent the entire month in a sharp decline, falling 12.5%, amid fallout from the discovery of more than two million illegally-opened credit card and deposit accounts.
The financial sector was followed by energy (+1.3%), which locked in a market-leading 3.0% gain for the month. The growth-sensitive sector outpaced crude oil, which climbed 0.8% to $48.11/bbl. The energy component gained 7.6% in September, but slipped 0.5% for the quarter.
Consumer staples (+1.0%) and health care (+1.0%) also spent the day among the leaders while other defensively-oriented sectors like utilities (-0.7%), telecom services (-0.3%), and real estate (-0.5%) lagged.
Elsewhere, the top-weighted technology sector (+0.6%) finished in the middle of the pack, masking relative strength among chipmakers as interest surrounding Qualcomm's (QCOM 68.50, +1.05) rumored acquisition of NXP Semiconductor (NXPI 102.02, +5.89) grew. NXP Semiconductor surged nearly 25.0% after Thursday's Wall Street Journal report brought the potential acquisition to light. The PHLX Semiconductor index advanced 1.6% on Friday.
Today's rally in stocks lured some money out of the Treasury market, sending the 10-yr yield higher by four basis points to 1.60%.
Quarter-end flows resulted in increased participation as more than 1.2 billion shares changed hands at the NYSE floor.
Economic data included Personal Income, Personal Spending, Core PCE Prices, Chicago PMI, and Michigan Sentiment:
- Personal income increased 0.2% month-over-month in August, as expected, while personal spending was unchanged (consensus +0.2%). Real personal spending ("real PCE"), though, was down 0.1%
- The decline in real PCE will weigh on Q3 GDP growth forecasts and leave the market in a confused state on the timing of the next rate hike since real PCE was weak in August while the inflation measures trended up
- The MNI Chicago Business Barometer jumped to 54.2 in September (consensus 52.0) from 51.5 in August. In the same period a year ago, the barometer stood at 47.8
- The final reading for the September Index of Consumer Sentiment checked in at 91.2. That was above the consensus estimate of 90.0 and up from the final reading of 89.8 for August
Monday's economic data will include the 10:00 ET release of August Construction Spending (consensus 0.2%) and September ISM Index (consensus 50.4) while auto and truck sales for September will be reported throughout the day.
- Russell 2000 +10.2% YTD
- Nasdaq Composite +6.1% YTD
- S&P 500 +6.1% YTD
- Dow Jones Industrial Average +5.1% YTD
In reaction to strong earnings/guidance: AEHR +7.4%, COST +1.9%, MKC +1.8%
M&A news:
- NXPI +3% (Hearing Jefferies out premarket suggesting co could garner $136-172 per share in a takeout)
- NVFY +1.2% (to sell NOVA BVI and its subsidiaries for $8.5 mln to Kuka Design)
Other news:
- AUPH +14.8% (announces that voclosporin achieves primary and all pre-specified secondary endpoints in Phase IIb AURA-LV study for Lupus Nephritis )
- MENT +5.3% ( Elliot Mgmt discloses 8.1% active stake -- has communicated with management and Board about a broad range of operational and strategic matters)
- OZM +5.1% (confirms reaching settlements w/ the DOJ and the SEC; will pay a total penalty of $412 mln; entered into a securities purchase agreement with certain executive managing directors)
- CEMP +4.3% (light volume - announces interim results showing anti-NASH effects in the first six nonalcoholic steatohepatitis patients dosed with solithromycin in a Phase 2 study)
- CATB +3.5% (Deerfield Mgmt (James Flynn) increases passive stake)
- AA +2% (approves proposed separation; separation is scheduled to become effective before the opening of the market on November 1, 2016)
- IBN +2% (rebounding from yesterday's selloff)
- HLIT +1.2% (Comcast confirms 6.6% passive stake -- the cos entered into a warrant agreement this week)
- ECA +2.5% (upgraded to Buy from Neutral at Citigroup)
- SKX +2.2% (upgraded to Positive from Neutral at Susquehanna)
- WMT +1% (initiated with a Overweight at KeyBanc Capital Mkts)
- NKTR +0.9% (resumed with a Buy at Brean Capital)
In reaction to disappointing earnings/guidance: CAMP -15.3%
Select oil/gas related names showing early weakness:
- SDRL -4.8%, SDPI -4.7%, TOT -1.7%, WLL -1.2%, COP -1%, RIG -0.8%, BT -0.7%, PBR -0.6%
- THLD -61.8% ( to discontinue investment in its Tarloxotinib Program after interim data; implementing workforce reduction)
- MIRN -17.1% (Mirna Therapeutics Investigational New Drug for MRX34 has been placed on full clinical hold)
- DCTH -13% ( intends to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering)
- ABUS -10.8% (reports interim results from the first two cohorts of the ongoing ARB-1467 Phase II multi-dose clinical trial in chronically infected HBV patients)
- VNRX -8.5% ( announces proposed public offering of common stock)
- CNO -3.9% (terminating reinsurance agreements with Beechwood Reand; will suspend its share repurchase program for the rest of 2016)
- STAY -3.6% (prices secondary offering and repurchase of paired shares; paired shares sold at $14.25 per share)
- ABR -2.9% (to offer $75 mln convertible senior notes due 2019 in an underwritten public offering)
- IRT -2.6% (prices public offering of 25 mln shares of common stock at $9.00 per share for total gross proceeds of $225.0 mln)
- SNE -2.2% (Nikkei down 1.5% overnight)